Skip to main content
Research: improving participation in colorectal cancer screening
Pages of the services concerned
News

Blue Mars

Research: improving participation in colorectal cancer screening

As part of the fight against colorectal cancer, a study commissioned by the National Cancer Institute ( INCA ) from INSERM Unit 1086 ANTICIPATE and promoted by Caen Normandy University Hospital is currently evaluating the impact of directly sending kits home screening. With participation in organized colorectal cancer screening (DOCCR) in France below 40%, this approach aims to improve the participation rate by eliminating the need for a medical consultation.

Goals

The EXPEDIT study, promoted by Caen Normandy University Hospital and carried out in the Centre-Val de Loire region, covers 64,000 people eligible for DOCCR. It aims to specifically examine the influence of direct mailing of the test on participation in screening and the rate of completion of colonoscopy in the event of a positive result, while evaluating the medico-economic efficiency.

Organized screening for colorectal cancer is recommended every 2 years, for women and men aged 50 to 74, without symptoms or history. The test can usually be collected from a doctor (general practitioner, gastroenterologist, gynecologist), in a pharmacy, or ordered online.

Assumptions and expectations

The fundamental hypothesis of the study is that sending screening kits directly to participants' homes will significantly improve the rate and time of participation in DOCCR, while preserving the colonoscopy rate. This approach could also prove economically viable.

This promising study is part of a strategic initiative to increase the effectiveness of colorectal cancer screening in France.

Communication department of Caen Normandy University Hospital
CHU Caen Normandy

Press contacts

Communication Department
Avenue de la Côte de Nacre
CS 30001
14033 CAEN cedex 9